Isoquercetin in Sickle Cell Anemia

NCT04474626 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Trial did not activate

Conditions

Sickle Cell Disease
Sickle Cell-Beta0-Thalassemia

Interventions

DRUG: Isoquercetin

Sponsor

Jeffrey Zwicker, MD

Collaborators

[object Object]